Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0217187B2 - - Google Patents
[go: Go Back, main page]

JPH0217187B2 - - Google Patents

Info

Publication number
JPH0217187B2
JPH0217187B2 JP57011687A JP1168782A JPH0217187B2 JP H0217187 B2 JPH0217187 B2 JP H0217187B2 JP 57011687 A JP57011687 A JP 57011687A JP 1168782 A JP1168782 A JP 1168782A JP H0217187 B2 JPH0217187 B2 JP H0217187B2
Authority
JP
Japan
Prior art keywords
skin
layer
conductive
conductor
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57011687A
Other languages
Japanese (ja)
Other versions
JPS58130054A (en
Inventor
Taichiro Inoe
Norie Kashima
Micho Morihata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Priority to JP1168782A priority Critical patent/JPS58130054A/en
Publication of JPS58130054A publication Critical patent/JPS58130054A/en
Publication of JPH0217187B2 publication Critical patent/JPH0217187B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】 本発明はイオントフオレーゼ用装置、特に人体
皮膚に直接貼着使用し得る極めて操作簡易且つ軽
量なイオントフオレーゼ用プラスター構造体に関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an iontophoresis device, and particularly to an extremely easy-to-operate and lightweight plaster structure for iontophoresis that can be directly attached to human skin.

イオン性薬剤の経皮吸収を促進する効果的な局
所投薬方法として、イオントフオレーゼは近時
益々注目されつつある(Glass JM et al.、Int.J.
Dermatol.19 519(1980);Russo J.、Am.J.
Hosp.Pharm.37 843(1980);Gangarosa LP et
al.、J.Pharmacol.Exp.Ther.212 377(1980;
Kwon BS et al.、J.Infect.Dis.140 1014
(1979);Hill JM et al.、Ann.NY.Acad.Sci.284
604(1977)及びTannebaum M.Phys.Ther.60
792(1980)、等々)。
Iontophoresis has recently received increasing attention as an effective topical administration method that promotes transdermal absorption of ionic drugs (Glass JM et al., Int.J.
Dermatol.19 519 (1980); Russo J., Am.J.
Hosp.Pharm.37 843 (1980); Gangarosa LP et
al., J.Pharmacol.Exp.Ther.212 377 (1980;
Kwon BS et al., J.Infect.Dis.140 1014
(1979); Hill JM et al., Ann.NY.Acad.Sci.284
604 (1977) and Tannebaum M.Phys.Ther.60
792 (1980), etc.).

これら先行技術に於けるイオントフオレーゼ
は、通常、持続平流発生装置又は断続平流発生装
置の出力端子と、薬液含浸脱指綿等で金属板等の
導体を被覆して成る関導子及び類似構成の不関導
子とを連結してなされるものであるためその実施
はかなり煩雑であり、投薬方法として極めて有効
なものであるにも拘らずその普及は限定されざる
を得ないものであつた。加えて、一般にはこれら
関導子等を治療部位にゴムバンド等で固定して経
皮通電するものであるため、皮膚と導子との接触
不良による火傷が生起し易く、施術中は不断に電
流計の監視を要する等、医家による場合はともか
く一般家庭用治療法としてのその普及は到底望み
得ようもなかつたものである。
Iontophoresis in these prior art is usually made by connecting the output terminal of a continuous current generator or an intermittent current generator to a conductor such as a metal plate, which is made by covering a conductor such as a metal plate with cotton wool impregnated with a chemical solution, or a similar structure. Because it is performed by connecting the drug to a nonconforming inductor, its implementation is quite complicated, and although it is extremely effective as a medication method, its widespread use has been limited. . In addition, these conductors are generally fixed to the treatment area with rubber bands, etc. to apply transdermal electricity, so burns are likely to occur due to poor contact between the skin and the conductor, so constant contact with the conductor is required during the treatment. Since it required monitoring with an ammeter, there was no hope that it would become popular as a general home treatment, even if it was only used by doctors.

故に、本発明の主たる目的はこれら公知技術の
諸困難を克服する、人体皮膚に直接貼着使用し得
る極めて操作簡易且つ軽量な新規イオントフオレ
ーゼ用プラスター構造体を提供することにある。
Therefore, the main object of the present invention is to provide a novel plaster structure for iontophoresis that overcomes the difficulties of these known techniques and is extremely easy to operate and lightweight, and can be used by directly adhering to the human skin.

以下、本発明の第1の実施例を図面第1図乃至
第3図を参照して詳細に説明する。図において1
はイオントフオレーゼ用プラスター構造体で、関
導子2と不関導子3とを有している。前記関導子
2は、吸水紙等の紙材、ガーゼ等の布材、脱指綿
等の繊維材、合成樹脂連続発泡体又は吸水性樹脂
等のスポンジ乃至多孔質材、等より成るイオン性
薬液含浸保持用吸水性部材層4と、アルミニウム
箔等の金属箔、導電性ゴム乃至樹脂フイルム等で
形成された電流分散用導電性部材層5とを例えば
ドータイト(登録商標)等の導電性接着剤などで
積層して一体的に形成したものである。また、不
関導子3は柔軟シート乃至フイルム状に形成され
た皮膚接着性の導電性ゲル層6と、前記と同様ア
ルミニウム箔等で形成された電流分散用導電性部
材層7とを積層して一体的に形成したものであ
る。前記関導子2の上面略中央部には軽量電池、
例えばいわゆるボタン状電池8がその一方の極例
えば(−)極が電流分散用導電性部材層5に接触
するように設置されている。またこのボタン状電
池8の(+)極はその両端近傍を除く下面に絶縁
コーテイングを施こした例えばアルミニウム箔の
リード線9により前記不関導子3の電流分散用導
電性部材層7に接続されている。10は絶縁性バ
ツキング層である。この絶縁性バツキング層10
は例えば非導電性の合成樹脂を柔軟シート乃至フ
イルム状に形成したもので、前記関導子2及び不
関導子3はこの絶縁バツキング層10に離間して
配置固着されている。すなわち、関導子2、不関
導子3及びボタン状電池8は絶縁バツキング層1
0により一体的に支持連結されている。
Hereinafter, a first embodiment of the present invention will be described in detail with reference to FIGS. 1 to 3 of the drawings. In the figure 1
1 is a plaster structure for iontophoresis, which has a separator 2 and a separator 3. The conductor 2 is an ionic material made of paper material such as water-absorbing paper, cloth material such as gauze, fiber material such as cotton wool, sponge or porous material such as open synthetic resin foam or water-absorbing resin, etc. The water-absorbing material layer 4 for holding the chemical impregnation and the current dispersing conductive material layer 5 formed of metal foil such as aluminum foil, conductive rubber or resin film, etc. are bonded together using a conductive adhesive such as Dotite (registered trademark). It is integrally formed by laminating layers with a compound or the like. In addition, the insensitivity conductor 3 is made by laminating a skin-adhesive conductive gel layer 6 formed in the form of a flexible sheet or film, and a current dispersion conductive member layer 7 formed of aluminum foil or the like as described above. It is integrally formed. A lightweight battery is located approximately at the center of the upper surface of the conductor 2.
For example, a so-called button-shaped battery 8 is installed such that one of its poles, for example, the (-) pole, is in contact with the current dispersion conductive member layer 5. Further, the (+) pole of this button-shaped battery 8 is connected to the current dispersion conductive material layer 7 of the indifferent conductor 3 by a lead wire 9 made of aluminum foil, for example, whose lower surface except near both ends is coated with an insulator. has been done. 10 is an insulating backing layer. This insulating backing layer 10
is made of, for example, a non-conductive synthetic resin in the form of a flexible sheet or film, and the conductor 2 and the conductor 3 are spaced apart and fixed to this insulating backing layer 10. That is, the inductor 2, the inductor 3, and the button-shaped battery 8 are connected to the insulating backing layer 1.
They are integrally supported and connected by 0.

次にこのように構成した本発明イオントフオレ
ーゼ用プラスター構造体の作用及び使用法を説明
する。まず関導子2の吸水性部材層4に所望のイ
オン性薬液を含浸せしめ、次いで人体の希望位置
に関導子2が当接するように貼着する。これと同
時に関導子2と不関導子3とは閉回路を形成し、
関導子2のイオン性薬液含浸用吸水性部材層4中
のイオン性薬剤の経皮浸透は加速される。
Next, the function and usage of the plaster structure for iontophoresis of the present invention constructed as described above will be explained. First, the water-absorbing material layer 4 of the separator 2 is impregnated with a desired ionic chemical solution, and then the separator 2 is attached to a desired position on the human body so as to come into contact with it. At the same time, Seki conductor 2 and Insen conductor 3 form a closed circuit,
Transdermal permeation of the ionic drug in the water-absorbing member layer 4 for impregnation with the ionic drug liquid of the seki-doshi 2 is accelerated.

本例プラスター構造体の各構成要素等に付き更
に詳細に分説すれば次の通りである。
Each component of the plaster structure of this example will be explained in more detail as follows.

皮膚接着性導電性ゲル層 この層は好適には、カラヤガム、トラガカント
ガム、ザンサンガム等の天然樹脂多糖類又はポリ
ビニルアルコール部分ケン化物、ポリビニルホル
マール、ポリビニルメチルエーテル及びそのコー
ポリマ、ポリビニルピロリドン、ポリビニルメタ
クリレート等のビニル系樹脂、ポリアクリル酸及
びそのナトリウム塩、ポリアクリルアミド及びそ
の部分加水分解物、ポリアクリル酸エステル部分
ケン化物、ポリ(アクリル酸−アクリルアミド)
等のアクリル系樹脂など、親水性を有する各種天
然又は合成樹脂類を水及び/又はエチレングリコ
ール、グリセリン等のアルコール類で柔軟可塑化
して自己保形性、皮膚接着性を有する柔軟フイル
ム乃至シート状ゲルとして提供される。
Skin-Adhesive Conductive Gel Layer This layer is preferably made of natural resin polysaccharides such as karaya gum, tragacanth gum, xanthan gum, or vinyl such as polyvinyl alcohol partially saponified products, polyvinyl formal, polyvinyl methyl ether and its copolymers, polyvinyl pyrrolidone, polyvinyl methacrylate, etc. system resin, polyacrylic acid and its sodium salt, polyacrylamide and its partially hydrolyzed product, partially saponified polyacrylic ester, poly(acrylic acid-acrylamide)
Various hydrophilic natural or synthetic resins, such as acrylic resins, are softened and plasticized with water and/or alcohols such as ethylene glycol and glycerin to produce flexible films or sheets that have self-shape retention and skin adhesion. Supplied as a gel.

他方、これに充分な導電性を付与すべく塩化ナ
トリウム、炭酸ナトリウム、くえん酸カリウム
等々の電解質が所要量(通常1〜15%程度)添加
される。このようにして得られる本発明で好適な
導電性ゲル層は、柔軟フイルム乃至シート状であ
つて皮膚に密接着し得るものであるため、皮膚接
触抵抗が低く薬剤イオンの経皮浸透に効果的であ
るのみならず、接着テープ等の他の皮膚接着手段
を要せず構造体全体を皮膚に貼着支持し得るとい
う使用上の利点をも併せ有するものである。特に
ゲル層の基材として前記カラヤガム等の天然樹脂
多糖類を使用した場合は、その天然高分子酸構造
によるPH緩衝性乃至皮膚保護性、著るしく高い保
水能力、適度な皮膚貼着性等により、単に電気化
学的に良好な導電性ゲルを提供し得るのみならず
好適な皮膚適合性が得られるものである。
On the other hand, electrolytes such as sodium chloride, sodium carbonate, potassium citrate, etc. are added in required amounts (usually about 1 to 15%) to impart sufficient electrical conductivity. The conductive gel layer suitable for the present invention obtained in this way is in the form of a flexible film or sheet and can be closely attached to the skin, so it has low skin contact resistance and is effective for transdermal penetration of drug ions. In addition, it also has the advantage of being able to adhere and support the entire structure to the skin without requiring other skin adhesion means such as adhesive tape. In particular, when a natural resin polysaccharide such as the aforementioned Karaya gum is used as the base material of the gel layer, its natural polymeric acid structure provides PH buffering properties, skin protection properties, extremely high water retention capacity, moderate adhesion to the skin, etc. This not only provides a gel with good electrochemical conductivity, but also provides suitable skin compatibility.

又、これらゲル層の組成配合に当つては、所謂
電気泳動用ゲルの場合とほぼ同様の電気化学的配
慮がなされるべきことは当然であるが、主として
使用薬剤の種類と所要投与量(用量)、貼着使用
時間、使用電池の出力及び皮膚接触面積等々によ
り、そのイオン・モビリテイ乃至電導度が所要値
になるように適宜実施されるものである。
In addition, when formulating the composition of these gel layers, it goes without saying that electrochemical considerations should be made in much the same way as in the case of so-called electrophoresis gels, but the main consideration is the type of drug used and the required dosage (dose). ), the duration of use of the adhesive, the output of the battery used, the skin contact area, etc., are carried out as appropriate so that the ion mobility or conductivity reaches the required value.

ここで、本例に於ける好適な導電性ゲル層の幾
つかをより具体的に示せば下記の通りである: 1 常法により、平均分子量44万、ケン化度約60
%のポリビニルアルコール粉末30gを調製し、
これに予め80℃に加熱された10%NaCl含有留
水40g及びグリセリン30gを添加、撹拌し、次
いで得られた混合物を80℃に加熱されたホツト
プレス機により圧力0.6Kg/cm2で約20分間加熱
加圧して厚さ3mmの柔軟シート状物を得た。こ
の柔軟シート状物は充分な皮膚接着性を有し且
つその比抵抗は0.8KΩ・cmであつた。
Here, some of the preferable conductive gel layers in this example are as follows: 1. The average molecular weight is 440,000 and the degree of saponification is about 60 using a conventional method.
Prepare 30g of % polyvinyl alcohol powder,
To this, 40 g of distilled water containing 10% NaCl and 30 g of glycerin, which had been preheated to 80°C, were added and stirred, and then the resulting mixture was heated to 80°C using a hot press machine at a pressure of 0.6 kg/cm 2 for about 20 minutes. A flexible sheet with a thickness of 3 mm was obtained by heating and pressing. This flexible sheet-like material had sufficient skin adhesion and had a specific resistance of 0.8 KΩ·cm.

2 上記1と同様にして下記組成により柔軟シー
ト状の導電性ゲル層を製造した。
2 A flexible sheet-like conductive gel layer was manufactured using the following composition in the same manner as in 1 above.

(組成例A) ポリビニルピロリドン(GAF社製PVP−
K90;平均分子量36万) …20g 10%NaCl含有蒸留水 …40g グリセリン …40g 得られたシートは強い皮膚接着性を有し且つ
その比抵抗は0.2KΩ・cmであつた。
(Composition Example A) Polyvinylpyrrolidone (PVP- manufactured by GAF)
K90; average molecular weight 360,000)...20g Distilled water containing 10% NaCl...40g Glycerin...40g The obtained sheet had strong skin adhesion and its specific resistance was 0.2KΩ·cm.

(組成例B) ポリビニルホルマール(平均分子量160万、ホ
ルマール化度15%;原料ポリビニルアルコール
のケン化度60%) …15g 5%NaCl含有蒸留水 …70g プロピレングリコール …15g 得られたシートは充分な皮膚接着性を有し、
その比抵抗は1.0KΩ・cmであつた。
(Composition example B) Polyvinyl formal (average molecular weight 1.6 million, degree of formalization 15%; degree of saponification of raw material polyvinyl alcohol 60%) ...15g Distilled water containing 5% NaCl ...70g Propylene glycol ...15g The obtained sheet has a sufficient amount of Has skin adhesive properties,
Its specific resistance was 1.0KΩ·cm.

(組成例C) ポリビニルアセトアセタール(平均分子量44
万、アセタール化度30%;出発ポリビニルアル
コールのケン化度70%) …40g 15%NaCl含有蒸留水 …50g エチレングリコール …10g 充分な皮膚粘着性を有し、比抵抗0.75KΩ・
cm。
(Composition example C) Polyvinyl acetoacetal (average molecular weight 44
(degree of acetalization: 30%; degree of saponification of starting polyvinyl alcohol: 70%)...40g Distilled water containing 15% NaCl...50g Ethylene glycol...10g Has sufficient skin adhesion and has a specific resistance of 0.75KΩ.
cm.

3 ポリアクリル酸ソーダ(日本純薬社製アロン
ビスSS;平均分子量300〜500万)20gを5%
NaCl含有蒸留水12g及びグリセリン溶液68g
と均一に混和し、80℃で10分間加熱加圧して柔
軟シート状物を得た。このシートは適度の皮膚
接着性を有し且つその比抵抗は1昼夜放置後で
0.5KΩ・cmであつた。
3 Sodium polyacrylate (Aronbis SS manufactured by Nippon Pure Chemical Industries, Ltd.; average molecular weight 3 million to 5 million) 20 g at 5%
12g of distilled water containing NaCl and 68g of glycerin solution
The mixture was mixed uniformly with the mixture and heated and pressed at 80°C for 10 minutes to obtain a flexible sheet. This sheet has moderate skin adhesion and its specific resistance after being left for one day and night.
It was 0.5KΩ・cm.

4 カラヤガム30gと5%NaCl含有蒸留水30g
及びグリセリン40gとを混和、加熱加圧して同
様にシートを作成した。比抵抗0.65KΩ・cm。
4 30g of Karaya gum and 30g of distilled water containing 5% NaCl
and 40 g of glycerin were mixed and heated and pressed to prepare a sheet in the same manner. Specific resistance 0.65KΩ・cm.

5 ポリアクリル酸ソーダ(日本純薬社製アロン
ビスS;平均分子量300〜500万)20gを7%
NaCl含有蒸留水80gと混和、加熱加圧して同
様にシートを作成した。比抵抗0.47KΩ・cm。
5 Sodium polyacrylate (Aronbis S manufactured by Nippon Pure Chemical Industries, Ltd.; average molecular weight 3 million to 5 million) 20 g 7%
A sheet was prepared in the same manner by mixing with 80 g of distilled water containing NaCl and applying heat and pressure. Specific resistance 0.47KΩ・cm.

上記から明らかな通り、本発明導電性ゲル層の
ゲル基材組成乃至範囲は特定のものに限定される
ものではなく広汎な親水性高分子類を水及び/又
はアルコール類にて柔軟可塑化して使用に共され
るものであるが、通常、保形性を有するためには
親水性高分子10〜70重量%及び残部水及び/又は
アルコールの組成範囲内で選択実施される。上記
例示の各導電性ゲル層はそれ自体が充分な皮膚粘
着性を有するものであるが、所望の場合、アクリ
ル系粘着剤、酢酸ビニルエマルジヨン系粘着剤等
の感圧性粘着成分を更に添加してもよい。
As is clear from the above, the gel base material composition or range of the conductive gel layer of the present invention is not limited to a specific one, and a wide range of hydrophilic polymers can be softened and plasticized with water and/or alcohols. Generally, in order to have shape retention properties, the composition is selected within the range of 10 to 70% by weight of the hydrophilic polymer and the balance water and/or alcohol. Each of the above-mentioned conductive gel layers has sufficient skin adhesion by itself, but if desired, a pressure-sensitive adhesive component such as an acrylic adhesive or a vinyl acetate emulsion adhesive may be added. It's okay.

イオン性薬剤 イオン解離性薬剤であれば全て使用し得るが、
イオントフオレーゼ分野に於いて既に汎用されて
いるものの1部を例示すれば次の通りである:ヨ
ードカリ、塩酸プロカイン、メリコール、ビタミ
ンB1、B2、B6、C等の各種皮膚ビタミン、ヒス
タミン、サリチル酸ナトリウム、デキサメタゾ
ン、エピネフエリン、ハイドロコルチゾン、イド
クソリジン、ウンデシレン酸塩、等々。
Ionic drugs All ion dissociative drugs can be used, but
Some examples of those already widely used in the field of iontophoresis are as follows: iodopotassium, procaine hydrochloride, melicol, various skin vitamins such as vitamin B 1 , B 2 , B 6 , C, and histamine. , sodium salicylate, dexamethasone, epinephrine, hydrocortisone, idoxolidine, undecylenate, etc.

軽量電池並びに出力 ボタン状電池、シート状電池等、皮膚粘着使用
し得る軽量のものならば種類のいかんを問わない
が、通常、その小型乃至柔軟性等により上記2者
が好適に使用される。
Lightweight battery and output Any type of battery may be used as long as it is lightweight and can be used for adhesion to the skin, such as a button-shaped battery or a sheet-shaped battery, but the above two types are usually preferably used due to their small size and flexibility.

他方、イオントフオレーゼの実施に要求される
電流値は、通常、数μA〜数100μA/cm2程度であ
り且つ導子と皮膚との接触抵抗は数KΩ〜数10K
Ω程度であるので、電池の出力は皮膚と導子との
接触面積にもよるが大略0.5〜10V程度である。
従つて、所要の場合はこれら軽量電池を数個配設
又は数枚積層使用してもよい。又、所要により定
電流素子や通電を表示すべく発光素子等を付加し
てもよい。
On the other hand, the current value required to perform iontophoresis is usually about several μA to several 100 μA/cm 2 , and the contact resistance between the conductor and the skin is from several KΩ to several tens of K.
Since the voltage is approximately Ω, the output of the battery is approximately 0.5 to 10 V, depending on the contact area between the skin and the conductor.
Therefore, if necessary, several of these lightweight batteries may be arranged or stacked. Further, if necessary, a constant current element or a light emitting element to indicate energization may be added.

吸水性部材 イオン性薬剤水溶液を含浸保持し得る材であれ
ば種類を問わず使用され得、吸水性紙材、布材、
スポンジ材、多孔質材等々を好適なものとして例
示し得る。
Water-absorbing member Any material can be used as long as it can impregnate and retain an aqueous ionic drug solution, such as water-absorbing paper, cloth,
Suitable examples include sponge materials, porous materials, and the like.

使用例 添付第1乃至3図に示す構造体の使用例の1つ
をより詳細に説明すれば下記の通りである。すな
わち、導電性ゲル層は前出ポリアクリル酸ナトリ
ウム(アロンビスS)20重量%、20%NaCl含有
蒸留水15重量%及びグリセリン65重量%より成る
厚さ1.5mm、面積約12cm2の皮膚接着性を有する粘
弾性ゲルであり、吸水性部材層は厚さ約1.7mm、
面積約6cm2のガーゼ材或いはポリビニルホルマー
ル・スポンジ材より形成されている。
Example of Use One example of the use of the structure shown in the attached FIGS. 1 to 3 will be described in more detail as follows. That is, the conductive gel layer is made of 20% by weight of the aforementioned sodium polyacrylate (Alonbis S), 15% by weight of distilled water containing 20% NaCl, and 65% by weight of glycerin, and has a thickness of 1.5 mm and an area of approximately 12 cm 2 and is skin adhesive. It is a viscoelastic gel with a thickness of about 1.7 mm.
It is made of gauze material or polyvinyl formal sponge material with an area of about 6 cm 2 .

他方、電流分散用導電性部材5,7はこの場合
アルミニウム箔を使用し、ボタン状電池8(出力
電圧1.5V)の陰極を直接関導子2に、陽極をリ
ード線9を介して不関導子3連結したものであ
り、更に、これら全体はポリエチレンフイルム1
0によりヒートシール法にて一体的に積層形成さ
れてプラスター構造体1が提供される。
On the other hand, the conductive members 5 and 7 for current distribution use aluminum foil in this case, and connect the cathode of the button-shaped battery 8 (output voltage 1.5 V) directly to the conductor 2, and the anode to the conductor 2 through the lead wire 9. 3 conductors are connected, and the whole is made of polyethylene film 1.
0, the plaster structure 1 is provided by integrally laminating the plaster structure 1 using a heat sealing method.

使用に当つては、吸水性部材層4に3%ビタミ
ンC含有水溶液(アンプル貯蔵)1〜数mlを滴下
含有せしめ、次いで患部に構造体全体を貼着して
施術が開始される。
In use, 1 to several ml of a 3% vitamin C-containing aqueous solution (stored in ampoules) is dripped into the water-absorbing member layer 4, and the entire structure is then adhered to the affected area to begin the treatment.

周知の通り、ビタミンC(アスコルビン酸)乃
至その誘導体(アスコルビン酸ナトリウム等)
は、所謂肝斑、雀卵斑、各種黒皮症等の色素沈着
性に有効なものであり、イオントフオレーゼによ
る施術も美容乃至皮膚科にあつては既にその有用
性が知られているものであるが、前述の通り操作
の煩雑により一般に普及を見ていないものであ
る。しかし乍ら、本例はこれによれば極めて簡易
な操作で当該施術可能となるものであり、治療乃
至美容用プラスターとして画期的なもの云い得
る。
As is well known, vitamin C (ascorbic acid) or its derivatives (sodium ascorbate, etc.)
It is effective for pigmentation such as so-called melasma, sparrow spots, and various melasma, and iontophoresis treatment is already known to be useful in beauty and dermatology. However, as mentioned above, it is not widely used due to the complicated operation. However, this example allows the treatment to be performed with extremely simple operations, and can be said to be revolutionary as a therapeutic or cosmetic plaster.

尚、本例の構成で顔面に貼着使用の場合、その
通電量は通常10〜80μA/cm2であり、ビタミンC
がメラノサイト含有表皮基底細胞層に到達する時
間は約20〜60分程度である。
In addition, when using the configuration of this example on the face, the amount of current is normally 10 to 80 μA/cm 2 , and vitamin C
It takes about 20 to 60 minutes for it to reach the melanocyte-containing epidermal basal cell layer.

尚、この使用例に於けるプラスター構造体はサ
リチル酸ナトリウム等を使用した場合鎮通・消炎
プラスターとし適用されるものであるが、この場
合、血管拡張作用を示す所謂平流療法
(Galvanization)が併せなされることになるの
で、神経通、関節通、リウマチ様関節炎等の疾患
に対して相乗的著効を示すものであることが理解
されよう。
In addition, the plaster structure in this usage example is applied as an anti-inflammatory plaster when sodium salicylate is used, but in this case, so-called galvanization, which has a vasodilatory effect, is also used. Therefore, it can be understood that the drug exhibits a synergistic effect on diseases such as nerve passage, joint passage, and rheumatoid arthritis.

その他のゲル基材 本発明導電性ゲル層のゲル基材の好適例の幾つ
かは先述した通りであるが、更に所謂生体用電極
材料等として公知の多様な親水性高分子材が随意
に選択使用され得るものであることが改めて指摘
される。例えば、特開昭52−95895、同56−
15728、同56−36939及び同56−36940等々に開示
の各種親水性高分子材は、その含水率等を適宜調
整することにより本発明導電性ゲル層のゲル基材
として使用し得るものである。
Other gel base materials Some preferred examples of the gel base material for the conductive gel layer of the present invention are as described above, but various hydrophilic polymer materials known as so-called biological electrode materials may also be selected at will. It is once again pointed out that it can be used. For example, JP-A-52-95895, JP-A-56-
Various hydrophilic polymer materials disclosed in Japanese Patent No. 15728, No. 56-36939, No. 56-36940, etc. can be used as the gel base material of the conductive gel layer of the present invention by appropriately adjusting their water content etc. .

このように、本発明導電性ゲル層のゲル基材は
親水性高分子であつて水及び/又はアルコール類
により柔軟可塑化されて皮膚接着性の粘弾性ゲル
を与えるものであれば足り、特定材に限定される
ものではなく、使用薬剤との適合性、皮膚適合性
及び導電性等を考慮してその基材組成が決定され
る。又、これらゲル層を使い捨てもしくは他の夫
と変換すること等は自在である。
As described above, it is sufficient that the gel base material of the conductive gel layer of the present invention is a hydrophilic polymer that can be softened and plasticized with water and/or alcohol to give a skin-adhesive viscoelastic gel. The composition of the base material is not limited to the material used, but the composition of the base material is determined in consideration of compatibility with the drug used, compatibility with the skin, electrical conductivity, etc. Furthermore, these gel layers can be disposable or replaced with other materials.

尚、有効薬剤イオン種の陰陽に応じて導子の陰
陽を自在に変換し得るべく極性切換手段を当該構
造体に付加してもよい。
Incidentally, a polarity switching means may be added to the structure so that the yin and yang of the conductor can be freely changed depending on the yin and yang of the effective drug ion species.

次に本発明イオントフオレーゼ用プラスター構
造体の第2の実施例を図面第4図を参照して詳細
に説明する。本実施例は軽量電池としてシート状
バツテリー15を使用したものである。。このシ
ート状バツテリー15の一面には例えば銅箔、カ
ーボン繊維不織布等で形成された電流分散用導電
性部材層16,17が配設されており、その一方
の極にはイオン性薬剤水溶液含浸保持用吸水性部
材層4が積層され、また他方の極には導電性ゲル
層6が積層配設されている。
Next, a second embodiment of the plaster structure for iontophoresis according to the present invention will be described in detail with reference to FIG. 4 of the drawings. In this embodiment, a sheet-shaped battery 15 is used as a lightweight battery. . On one side of this sheet-like battery 15, conductive member layers 16 and 17 for current dispersion made of copper foil, carbon fiber nonwoven fabric, etc. are disposed, and one pole thereof is impregnated with an aqueous solution of an ionic drug and held therein. A water-absorbing member layer 4 is laminated thereon, and a conductive gel layer 6 is laminated on the other pole.

本実施例の構成によると、シート状バツテリー
は0.5mm〜2mmと極めて薄いためプラスター構造
体1全体の厚さも極めて薄くなり、また凸部の全
くないスマートなプラスター構造体が得られる。
According to the configuration of this embodiment, since the sheet-like battery is extremely thin at 0.5 mm to 2 mm, the thickness of the entire plaster structure 1 is also extremely thin, and a smart plaster structure without any convex portions can be obtained.

尚、シート状バツテリーの出力端子を面状に形
成し、この出力端子を各電流分散用導電性部材層
としたものであつても良い。
Note that the output terminal of the sheet-like battery may be formed into a planar shape, and this output terminal may be used as each current dispersion conductive member layer.

このように、構造体の周辺部乃至端部等に皮膚
接着性且つ導電性のゲル層を配置することによ
り、接着テープ等の他の固定手段を何ら要せずに
当該構造体全体が皮膚に固定保持される。
In this way, by arranging the skin-adhesive and conductive gel layer around the periphery or end of the structure, the entire structure can be attached to the skin without the need for any other fixing means such as adhesive tape. It is held fixed.

所要の場合、保水性部材層を着脱自在にし、予
め薬液含浸済の当該部材を使用時に構造体所定位
に配置、施術使用してもよい。又、吸水性部材に
代えて、寒天ゲル、ゼラチンゲル等の電気泳動分
野でも汎用の非粘着性ハイドロゲルを使用しても
よいことは明らかである。寒天水ゲル組成の1例
を示せば次の通りである。
If necessary, the water-retaining member layer may be made removable, and the member impregnated with a chemical solution may be placed at a predetermined position in the structure at the time of use and used for treatment. Furthermore, it is clear that in place of the water-absorbing member, non-adhesive hydrogels commonly used in the field of electrophoresis, such as agar gel and gelatin gel, may be used. An example of an agar water gel composition is as follows.

寒天末 4.0重量部 精製水 100.0 〃 ビタミンC(アスコルビン酸:そのNa塩〜1:
1) 5.0 〃 この種のハイドロゲル片は、予め構造的に積層
配置されてもよく、或いは前述の通り使用時に配
置されるようにしてもよい。
Agar powder 4.0 parts by weight Purified water 100.0 Vitamin C (ascorbic acid: its Na salt ~ 1:
1) 5.0 This kind of hydrogel pieces may be arranged in advance in a structural manner, or they may be arranged in use as described above.

以上から明らかなように、本発明プラスター構
造体は効果的な投薬促進方法であるイオントフオ
レーゼを著るしく簡易な操作で施術可能とし且つ
複雑大型な装置を要せずしかも安全確実に実施し
得るという著効を奏効するものである。
As is clear from the above, the plaster structure of the present invention allows iontophoresis, which is an effective method for promoting drug administration, to be performed with a significantly simple operation, does not require complicated and large equipment, and can be performed safely and reliably. It has a remarkable effect of obtaining.

【図面の簡単な説明】[Brief explanation of drawings]

第1図乃至第3図は本発明イオントフオレーゼ
用プラスター構造体の第1の実施例を示し、第1
図はその平面図、第2図は第1図の−線に沿
つた断面図、第3図は底面図を示す。第4図は同
第2の実施例を示す断面図である。 1……イオントフオレーゼ用プラスター構造
体、2……関導子、3……不関導子、4……イオ
ン性薬液含浸用吸水性部材層、5,16……関導
子の電流分散用導電性部材層、6……皮膚接着性
導電性ゲル層、7,17……不関導子の電流分散
用導電性部材層、8……ボタン状電池(軽量電
池)、15……シート状バツテリー(軽量電池)。
1 to 3 show a first embodiment of the plaster structure for iontophoresis of the present invention.
The figure shows a plan view, FIG. 2 a sectional view taken along the line - in FIG. 1, and FIG. 3 a bottom view. FIG. 4 is a sectional view showing the second embodiment. DESCRIPTION OF SYMBOLS 1...Plaster structure for iontophoresis, 2...Seki conductor, 3...Seki conductor, 4...Water absorbent material layer for impregnation with ionic chemical solution, 5, 16... Current dispersion of Seki conductor 6... Skin-adhesive conductive gel layer, 7, 17... Conductive material layer for current dispersion of indifferent conductors, 8... Button-shaped battery (lightweight battery), 15... Sheet Type battery (lightweight battery).

Claims (1)

【特許請求の範囲】[Claims] 1 イオン性薬液含浸用吸水性部材層と電流分散
用導電性部材層とを一体的に積層して成る関導子
と、自己保形性及び皮膚接着性を併せ有する柔軟
シート乃至フイルム状の導電性ゲル層と電流分散
用導電性部材層とを一体的に積層して成る不関導
子と、軽量電池により駆動されるイオントフオレ
ーゼ用装置との組合せ構造体から成り、前記組合
せ構造体が前記各導子の皮膚接着性により皮膚に
一体的に貼着使用し得るように、前記各導子と前
記イオントフオレーゼ用装置とが一体的に支持連
結されていることを特徴とするイオントフオレー
ゼ用プラスター構造体。
1. A conductor formed by integrally laminating a water-absorbing material layer for impregnation with an ionic chemical solution and a conductive material layer for current dispersion, and a flexible sheet or film-like conductive material having both self-shape retention and skin adhesion properties. It consists of a combination structure of an indifferent conductor formed by integrally laminating a conductive gel layer and a conductive material layer for current dispersion, and an iontophoresis device driven by a lightweight battery, and the combination structure An iontophoresis device characterized in that each of the conductors and the iontophoresis device are integrally supported and connected so that the conductors can be integrally attached to the skin due to their skin-adhesive properties. Plaster structure for Reese.
JP1168782A 1982-01-29 1982-01-29 Plaster structure for iontophoresis Granted JPS58130054A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1168782A JPS58130054A (en) 1982-01-29 1982-01-29 Plaster structure for iontophoresis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1168782A JPS58130054A (en) 1982-01-29 1982-01-29 Plaster structure for iontophoresis

Publications (2)

Publication Number Publication Date
JPS58130054A JPS58130054A (en) 1983-08-03
JPH0217187B2 true JPH0217187B2 (en) 1990-04-19

Family

ID=11784927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1168782A Granted JPS58130054A (en) 1982-01-29 1982-01-29 Plaster structure for iontophoresis

Country Status (1)

Country Link
JP (1) JPS58130054A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184575B (en) * 1982-07-16 1984-09-28 Otto Mallasz Method for producing preparations fixable on skin generating locally electrolytic and bio currents
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
JPS61146271A (en) * 1984-12-20 1986-07-03 ワコ−トレ−デイング株式会社 Adhesive drug
JPS62268569A (en) * 1986-05-19 1987-11-21 株式会社アドバンス Reservoir electrode for iontophoresis
JPH0197475A (en) * 1987-10-09 1989-04-14 Watanabe Wataru Electric treatment device
DE19848649C5 (en) 1998-10-22 2008-11-27 Peter Greiner Carbon piston for an internal combustion engine
FR3034017B1 (en) * 2015-03-24 2018-11-02 Feeligreen ADHESIVE POLYMERIC MATRIX FOR IONTOPHORESIS AND DEVICE FOR IONTOPHORESIS COMPRISING SAID MATRIX

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
ES486582A1 (en) * 1978-12-11 1980-06-16 Medtronic Inc Tape electrode.
JPS5652072A (en) * 1979-10-04 1981-05-09 Tokyo Electric Co Ltd Conductor for lowwfrequency treating instrument
JPS5671278A (en) * 1979-11-14 1981-06-13 Matsushita Electric Ind Co Ltd Lithium-iodine complex battery with solid electrolyte

Also Published As

Publication number Publication date
JPS58130054A (en) 1983-08-03

Similar Documents

Publication Publication Date Title
US4474570A (en) Iontophoresis device
EP0138347B1 (en) An iontophoresis device
US5685837A (en) Galvanically active transdermal therapeutic system
EP0754077B1 (en) Electrotransport device having improved cathodic electrode assembly
CA2038968C (en) Iontophoretic delivery device
CA2041994C (en) Iontophoretic delivery device
US5162043A (en) Iontophoretic delivery device
US20020058903A1 (en) Anhydrous drug reservoir for electrolytic transdermal delivery device
JPH07507465A (en) Iontophoretic drug administration device
EP0308572B1 (en) An iontophoresis device
US5376107A (en) Electrotherapeutic device
JPH0245461B2 (en)
JPH0217187B2 (en)
JPH0248262B2 (en)
JP2839279B2 (en) Device for iontophoresis
JPH0349589B2 (en)
JPS60188176A (en) Device for iontophorese
JPS6131169A (en) Device for iontophoresis